387 related articles for article (PubMed ID: 17035633)
1. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2.
Masckauchán TN; Agalliu D; Vorontchikhina M; Ahn A; Parmalee NL; Li CM; Khoo A; Tycko B; Brown AM; Kitajewski J
Mol Biol Cell; 2006 Dec; 17(12):5163-72. PubMed ID: 17035633
[TBL] [Abstract][Full Text] [Related]
2. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways.
Samarzija I; Sini P; Schlange T; Macdonald G; Hynes NE
Biochem Biophys Res Commun; 2009 Aug; 386(3):449-54. PubMed ID: 19523451
[TBL] [Abstract][Full Text] [Related]
3. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-secreted Wnt5a interacts with FZD5 in microvascular endothelial cells and induces angiogenesis through tissue factor signaling.
Arderiu G; Espinosa S; Peña E; Aledo R; Badimon L
J Mol Cell Biol; 2014 Oct; 6(5):380-93. PubMed ID: 25240054
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a signaling controls cytokinesis by correctly positioning ESCRT-III at the midbody.
Fumoto K; Kikuchi K; Gon H; Kikuchi A
J Cell Sci; 2012 Oct; 125(Pt 20):4822-32. PubMed ID: 22825874
[TBL] [Abstract][Full Text] [Related]
6. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
7. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression.
Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y
J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168
[TBL] [Abstract][Full Text] [Related]
8. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis.
Ho HY; Susman MW; Bikoff JB; Ryu YK; Jonas AM; Hu L; Kuruvilla R; Greenberg ME
Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4044-51. PubMed ID: 22343533
[TBL] [Abstract][Full Text] [Related]
10. Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain.
Rawal N; Castelo-Branco G; Sousa KM; Kele J; Kobayashi K; Okano H; Arenas E
Exp Cell Res; 2006 May; 312(9):1626-36. PubMed ID: 16510140
[TBL] [Abstract][Full Text] [Related]
11. Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension.
Ye Z; Zhang C; Tu T; Sun M; Liu D; Lu D; Feng J; Yang D; Liu F; Yan X
Nat Commun; 2013; 4():2803. PubMed ID: 24335906
[TBL] [Abstract][Full Text] [Related]
12. Dissection of sets of genes that control the character of wnt5a-deficient mouse calvarial cells.
Guo J; Jin J; Cooper LF
Bone; 2008 Nov; 43(5):961-71. PubMed ID: 18656562
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.
Kim J; Kim J; Kim DW; Ha Y; Ihm MH; Kim H; Song K; Lee I
J Immunol; 2010 Jul; 185(2):1274-82. PubMed ID: 20554957
[TBL] [Abstract][Full Text] [Related]
14. Functional consequences of Wnt-induced dishevelled 2 phosphorylation in canonical and noncanonical Wnt signaling.
González-Sancho JM; Greer YE; Abrahams CL; Takigawa Y; Baljinnyam B; Lee KH; Lee KS; Rubin JS; Brown AM
J Biol Chem; 2013 Mar; 288(13):9428-37. PubMed ID: 23396967
[TBL] [Abstract][Full Text] [Related]
15. Evidence for altered Wnt signaling in psoriatic skin.
Gudjonsson JE; Johnston A; Stoll SW; Riblett MB; Xing X; Kochkodan JJ; Ding J; Nair RP; Aphale A; Voorhees JJ; Elder JT
J Invest Dermatol; 2010 Jul; 130(7):1849-59. PubMed ID: 20376066
[TBL] [Abstract][Full Text] [Related]
16. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
[TBL] [Abstract][Full Text] [Related]
17. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
18. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
19. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
20. Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.
Pulvirenti T; Van Der Heijden M; Droms LA; Huse JT; Tabar V; Hall A
Cancer Res; 2011 Dec; 71(23):7280-90. PubMed ID: 21990322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
